Full Access with Signal8 Pro, $49/mo billed annually.
Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-related products), and veterinary care items.
Sector: Pharmaceutical Preparations
Industry: Drug Manufacturers - Specialty & Generic
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 11.18M shares outstanding
Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use.
The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-related products), and veterinary care items.
Adam Bendell
President of U.S. Operations
Bradley Glenn Karp
Head of Sales & Marketing
Matthew Jones
Head of Sports Performance
Nathan Jacob Givoni
Co-Founder, Chief Executive Officer & Executive Director
Employees
18
Country
AU
Sector
Healthcare
Website
gelteq.com
Loading congressional disclosures…
based on 11.18M shares outstanding
30d Avg
1.79M
60d Avg
4.41M
90d Avg
2.91M